Artificial Intelligence Technologies for COVID-19 De Novo Drug Design

Artificial Intelligence Technologies for COVID-19 De Novo Drug Design

The recent covid crisis has provided important lessons for academia and industry regarding digital reorganization. Among the fascinating lessons from these times is the huge potential of data analytics and artificial intelligence. The crisis exponentially accelerated the adoption of analytics and ar...

Full description

Bibliographic Details
Main Authors: Giuseppe Floresta, Chiara Zagni, Davide Gentile, Vincenzo Patamia, Antonio Rescifina
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
artificial intelligence
machine learning
drug design
COVID-19
structure-based drug design
ligand-based drug design
Online Access:https://www.mdpi.com/1422-0067/23/6/3261

Internet

https://www.mdpi.com/1422-0067/23/6/3261

Similar Items